Cancer Communications
indexed by SCI
BMC


ORIGINAL ARTICLE
Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study
Zhi Peng, Tianshu Liu, Jia Wei, Airong Wang, Yifu He, Liuzhong Yang, Xizhi Zhang, Nanfeng Fan, Suxia Luo, Zhen Li, Kangsheng Gu, Jianwei Lu, Jianming Xu, Qingxia Fan, Ruihua Xu, Liangming Zhang, Enxiao Li, Yuping Sun, Guohua Yu, Chunmei Bai, Yong Liu, Jiangzheng Zeng, Jieer Ying, Xinjun Liang, Nong Xu, Chao Gao, Yongqian Shu, Dong Ma, Guanghai Dai, Shengmian Li, Ting Deng, Yuehong Cui, Jianmin Fang, Yi Ba, Lin Shen
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/19/2021   doi:10.1002/cac2.12214
LETTER TO THE EDITOR
Licochalcone A suppresses Sp1 expression with potential anti-myeloma activity
Hua Bai, Min Zhou, He Zhou, Qiaoyan Han, Han Xu, Peipei Xu, Bing Chen
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/19/2021   doi:10.1002/cac2.12223
EDITORIAL
Phospholipase iPLA2β acts as a guardian against ferroptosis
Chao Mao, Guang Lei, Li Zhuang, Boyi Gan
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/17/2021   doi:10.1002/cac2.12231
RESEARCH HIGHLIGHT
Single whole-genome sequencing analysis of metastatic biopsy is sufficient for investigational treatment opportunities in cancer
Xifeng Dong, Rong Fu
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/17/2021   doi:10.1002/cac2.12232
REVIEW
Combined treatment of non-small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
Shijie Shang, Jie Liu, Vivek Verma, Meng Wu, James Welsh, Jinming Yu, Dawei Chen
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/17/2021   doi:10.1002/cac2.12226
LETTER TO THE EDITOR
Clinical characteristics and outcomes of Chinese patients with KRAS-mutant non-small cell lung cancer after chemotherapy
Yawen Zheng, Qinghua Lai, Hanxi Zhao, Xiaolin Li, Xiaorong Sun, Ligang Xing
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/17/2021   doi:10.1002/cac2.12227
LETTER TO THE EDITOR
Nut and peanut butter consumption and risk of prostate cancer in the NIH-AARP diet and health study
Mimi Ton, Leah M. Ferrucci, Stephanie J. Weinstein, Maryam Hashemian, Demetrius Albanes, Jiaqi Huang
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/17/2021   doi:10.1002/cac2.12230
REVIEW
Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine
Zi-Hang Chen, Li Lin, Chen-Fei Wu, Chao-Feng Li, Rui-Hua Xu, Ying Sun
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 10/6/2021   doi:10.1002/cac2.12215
ORIGINAL ARTICLE
A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors
Lili Lu, Christina S. Mullins, Clemens Schafmayer, Sebastian Zei?ig, Michael Linnebacher
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 9/25/2021   doi:10.1002/cac2.12220
RESEARCH HIGHLIGHT
Transcriptional suppression of CD8+ T cell exhaustion for improving T cell immunotherapy
Xue Yang, Bingjing Wang, Xuetao Cao
Cancer Communications 2021 41:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 9/23/2021   doi:10.1002/cac2.12222

<<    Page 1 of 42  >>    




CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China